Condition
Hypertension Associated
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
100%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 3 (2)
Trial Status
Withdrawn2
Clinical Trials (2)
Showing 2 of 2 trials
NCT04970108Phase 3WithdrawnPrimary
Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension
NCT05144360Phase 3WithdrawnPrimary
Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension
Showing all 2 trials